Aderis Pharmaceuticals, Inc. was a biopharmaceutical company specializing in the treatment of cardiovascular, renal and neurological diseases.

The company’s expertise was in the discovery and development of small-molecule drug candidates that act selectively on enzymes or subtypes of receptors that regulate important physiological processes.

In 2005 Aderis Pharmaceuticals, Inc. was acquired by Schwarz Pharma, Inc., a German pharmaceutical company.